company background image
PRIM

Royal Prima IDX:PRIM Stock Report

Last Price

Rp302.00

Market Cap

Rp895.4b

7D

11.0%

1Y

65.0%

Updated

18 May, 2022

Data

Company Financials
PRIM fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends0/6

PRIM Stock Overview

PT Royal Prima Tbk provides hospital services in Indonesia.

Royal Prima Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Royal Prima
Historical stock prices
Current Share PriceRp302.00
52 Week HighRp625.00
52 Week LowRp180.00
Beta0.031
1 Month Change-4.43%
3 Month Change-19.25%
1 Year Change65.03%
3 Year Change-32.89%
5 Year Changen/a
Change since IPO-59.73%

Recent News & Updates

Shareholder Returns

PRIMID HealthcareID Market
7D11.0%3.4%-1.0%
1Y65.0%16.8%18.2%

Return vs Industry: PRIM exceeded the ID Healthcare industry which returned 14.4% over the past year.

Return vs Market: PRIM exceeded the ID Market which returned 15.6% over the past year.

Price Volatility

Is PRIM's price volatile compared to industry and market?
PRIM volatility
PRIM Average Weekly Movement5.8%
Healthcare Industry Average Movement5.5%
Market Average Movement6.3%
10% most volatile stocks in ID Market12.2%
10% least volatile stocks in ID Market3.0%

Stable Share Price: PRIM is not significantly more volatile than the rest of ID stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: PRIM's weekly volatility has decreased from 13% to 6% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2013823Tommy Leonardhttps://www.royalprima.com

PT Royal Prima Tbk provides hospital services in Indonesia. The company was founded in 2013 and is headquartered in Jakarta, Indonesia.

Royal Prima Fundamentals Summary

How do Royal Prima's earnings and revenue compare to its market cap?
PRIM fundamental statistics
Market CapRp895.43b
Earnings (TTM)Rp125.91b
Revenue (TTM)Rp619.09b

8.1x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PRIM income statement (TTM)
RevenueRp619.09b
Cost of RevenueRp405.06b
Gross ProfitRp214.03b
Other ExpensesRp88.12b
EarningsRp125.91b

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)37.12
Gross Margin34.57%
Net Profit Margin20.34%
Debt/Equity Ratio0%

How did PRIM perform over the long term?

See historical performance and comparison

Valuation

Is Royal Prima undervalued compared to its fair value and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


8.14x

Price to Earnings (PE) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate PRIM's fair value for valuation analysis.


Price To Earnings Ratio

PE vs Industry: PRIM is good value based on its PE Ratio (8.1x) compared to the ID Healthcare industry average (20.2x).

PE vs Market: PRIM is good value based on its PE Ratio (8.1x) compared to the ID market (18.8x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate PRIM's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: PRIM is good value based on its PB Ratio (1x) compared to the ID Healthcare industry average (1.9x).


Future Growth

How is Royal Prima forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


16.7%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Royal Prima has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Royal Prima performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


57.5%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: PRIM has high quality earnings.

Growing Profit Margin: PRIM's current net profit margins (20.3%) are higher than last year (8.8%).


Past Earnings Growth Analysis

Earnings Trend: PRIM's earnings have grown significantly by 57.5% per year over the past 5 years.

Accelerating Growth: PRIM's earnings growth over the past year (594.3%) exceeds its 5-year average (57.5% per year).

Earnings vs Industry: PRIM earnings growth over the past year (594.3%) exceeded the Healthcare industry 121.6%.


Return on Equity

High ROE: PRIM's Return on Equity (12.7%) is considered low.


Financial Health

How is Royal Prima's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its short term liabilities (IDR167.1B).

Long Term Liabilities: PRIM's short term assets (IDR455.2B) exceed its long term liabilities (IDR8.3B).


Debt to Equity History and Analysis

Debt Level: PRIM is debt free.

Reducing Debt: PRIM has no debt compared to 5 years ago when its debt to equity ratio was 10.1%.

Debt Coverage: PRIM has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: PRIM has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Royal Prima current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate PRIM's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate PRIM's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if PRIM's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if PRIM's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as PRIM has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

7.3yrs

Average board tenure


CEO

Tommy Leonard (35 yo)

no data

Tenure

Dr. Tommy Leonard has been the President Director of PT Royal Prima Tbk since 2015. Dr. Leonard holds Bachelor’s Degree in Law, Dharmawangsa University (2008) Magister in Notary and Doctor of Law North Sum...


Board Members

Experienced Board: PRIM's board of directors are considered experienced (7.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

PT Royal Prima Tbk's employee growth, exchange listings and data sources


Key Information

  • Name: PT Royal Prima Tbk
  • Ticker: PRIM
  • Exchange: IDX
  • Founded: 2013
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Implied Market Cap: Rp895.430b
  • Shares outstanding: 3.39b
  • Website: https://www.royalprima.com

Number of Employees


Location

  • PT Royal Prima Tbk
  • Jalan Letjen S Parman
  • Kav. 22 - 24
  • Jakarta
  • Jakarta Raya
  • Indonesia

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/18 00:00
End of Day Share Price2022/05/18 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.